Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Norvet Pharma AB
AB
Active
Org 5590053897
Farhultsvägen 176-25, 263 95
Farhult
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 2015 · 11 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Norvet Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 1M
1M
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
680
631
224
641
569
Staff expenses
—
—
—
—
—
EBITDA
425
324
−83
316
388
Depreciation & amort.
—
—
−0
—
−0
EBIT
425
324
−83
316
388
Net financials
4
7
−1
−0
—
Profit before tax
368
261
5
241
293
Tax
−77
−54
−4
−50
−60
Net profit
291
207
1
191
233
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
815
739
450
691
656
Equity
387
346
139
333
342
Long-term debt
—
—
0
—
0
Short-term debt
48
74
63
19
51
Total debt
48
74
63
19
51
Financial ratios
5-year trend
EBITDA margin
62,5 %
This company
15,8 %
Market median
This company
Market median
296% above market
2021
2025
Equity ratio
47,5 %
This company
38,2 %
Market median
This company
Market median
24% above market
2021
2025
Return on equity
75,2 %
This company
18,4 %
Market median
This company
Market median
309% above market
2021
2025
Net profit margin
42,8 %
This company
8,1 %
Market median
This company
Market median
428% above market
2021
2025
Asset turnover
0,83×
This company
1,12×
Market median
This company
Market median
26% below market
2021
2025
Debt / equity
1,11×
This company
0,62×
Market median
This company
Market median
79% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Norvet Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
